TOP3A
Basic information
Region (hg38): 17:18271428-18315007
Previous symbols: [ "TOP3" ]
Links
Phenotypes
GenCC
Source:
- microcephaly, growth restriction, and increased sister chromatid exchange 2 (Definitive), mode of inheritance: AR
- progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5 (Strong), mode of inheritance: AR
- microcephaly, growth restriction, and increased sister chromatid exchange 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Microcephaly, growth restriction, and increased sister chromatid exchange 2; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5 | AR | Allergy/Immunology/Infectious; Cardiovascular | In Microcephaly, growth restriction, and increased sister chromatid exchange 2, the condition can include frequent infections, and awareness may allow early and aggressive treatment of infections; Individuals have been described with cardiomyopathy, and awareness may allow surveillance and prompt management; In Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5, the condition may involve cardiac dysfunction, and awareness may allow early detection and management | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic | 29290614; 30057030 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (9 variants)
- Microcephaly, growth restriction, and increased sister chromatid exchange 2 (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TOP3A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 102 | 108 | ||||
missense | 126 | 140 | ||||
nonsense | 4 | |||||
start loss | 1 | |||||
frameshift | 11 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 1 | 11 | 4 | 16 | ||
non coding | 43 | 54 | ||||
Total | 9 | 8 | 135 | 154 | 20 |
Highest pathogenic variant AF is 0.0000592
Variants in TOP3A
This is a list of pathogenic ClinVar variants found in the TOP3A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-18274804-ATCTGT-A | Uncertain significance (Dec 07, 2021) | |||
17-18274818-CA-C | Uncertain significance (Aug 09, 2022) | |||
17-18274827-C-CG | Uncertain significance (Aug 19, 2022) | |||
17-18274834-G-A | Uncertain significance (May 16, 2022) | |||
17-18274846-G-A | Uncertain significance (Jul 06, 2022) | |||
17-18274862-C-T | Likely benign (Nov 14, 2022) | |||
17-18274863-C-T | Uncertain significance (Dec 30, 2023) | |||
17-18274905-C-T | Uncertain significance (Aug 09, 2022) | |||
17-18274921-T-C | Uncertain significance (Apr 18, 2023) | |||
17-18274928-C-T | Likely benign (Jul 10, 2023) | |||
17-18274929-G-A | Inborn genetic diseases | Conflicting classifications of pathogenicity (Feb 10, 2023) | ||
17-18274955-T-C | Likely benign (Oct 13, 2023) | |||
17-18274976-A-T | Likely benign (Nov 17, 2022) | |||
17-18274985-C-T | Likely benign (Jan 10, 2023) | |||
17-18274998-G-A | Likely benign (Nov 04, 2023) | |||
17-18275000-A-G | Likely benign (Jan 26, 2023) | |||
17-18277661-C-T | Likely benign (Aug 28, 2022) | |||
17-18277681-C-T | Inborn genetic diseases | Uncertain significance (Aug 21, 2023) | ||
17-18277682-G-A | Benign/Likely benign (Jan 26, 2024) | |||
17-18277682-G-T | Benign (Jan 04, 2024) | |||
17-18277693-C-T | Uncertain significance (Feb 24, 2022) | |||
17-18277694-G-A | Likely benign (Nov 27, 2023) | |||
17-18277723-C-A | Microcephaly, growth restriction, and increased sister chromatid exchange 2 | Uncertain significance (Feb 02, 2022) | ||
17-18277727-C-T | Likely benign (May 18, 2022) | |||
17-18277728-G-A | Inborn genetic diseases | Uncertain significance (Jul 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TOP3A | protein_coding | protein_coding | ENST00000321105 | 19 | 43580 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.10e-11 | 1.00 | 125580 | 1 | 167 | 125748 | 0.000668 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.31 | 493 | 582 | 0.847 | 0.0000327 | 6548 |
Missense in Polyphen | 158 | 222.98 | 0.70858 | 2456 | ||
Synonymous | -1.08 | 248 | 227 | 1.09 | 0.0000132 | 1963 |
Loss of Function | 3.42 | 26 | 52.8 | 0.492 | 0.00000299 | 565 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000565 | 0.000563 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000277 | 0.000272 |
Finnish | 0.000323 | 0.000323 |
European (Non-Finnish) | 0.000581 | 0.000580 |
Middle Eastern | 0.000277 | 0.000272 |
South Asian | 0.00235 | 0.00232 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand then undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone. Essential component of the RMI complex, a complex that plays an important role in the processing of homologous recombination intermediates to limit DNA crossover formation in cells. Has DNA decatenation activity. {ECO:0000269|PubMed:20445207, ECO:0000269|PubMed:8622991}.;
- Pathway
- Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;Gene expression (Transcription);DNA Double-Strand Break Repair;Generic Transcription Pathway;Homology Directed Repair;RNA Polymerase II Transcription;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;Fanconi anemia pathway;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53;Cell Cycle;Processing of DNA double-strand break ends;ATM pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Resolution of D-loop Structures through Holliday Junction Intermediates;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Resolution of D-Loop Structures;HDR through Homologous Recombination (HRR)
(Consensus)
Recessive Scores
- pRec
- 0.0939
Intolerance Scores
- loftool
- 0.856
- rvis_EVS
- 0.3
- rvis_percentile_EVS
- 71.7
Haploinsufficiency Scores
- pHI
- 0.562
- hipred
- Y
- hipred_score
- 0.706
- ghis
- 0.492
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.731
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Top3a
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Zebrafish Information Network
- Gene name
- top3a
- Affected structure
- T cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- DNA replication;DNA topological change;mitochondrial DNA metabolic process;chromosome separation;meiotic cell cycle
- Cellular component
- nucleus;nucleoplasm;chromosome;mitochondrion;PML body
- Molecular function
- DNA binding;single-stranded DNA binding;DNA topoisomerase activity;DNA topoisomerase type I activity;protein binding;zinc ion binding